Oral Vitamin D(3) is usually administered to children with chronic renal failure in the morning. Is there enough evidence that evening dosing is more beneficial with respect to suppression of parathyroid hormone and reduction of side effects such as hypercalcemia?
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00467-004-1477-1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!